Discover
MBRX
Moleculin Biotech, Inc.
2.69
7 x 2.55
2 x 3.27
bid
ask
-
0.10
3.58%
5 @ 06:25 AM
2.50 -0.19 (7.06%)
| Ytd | -18.73% | |
| 1y | -69.08% |
2.53
day range
2.75
1.79
52 week range
24.00
| Open | 2.59 | Prev Close | 2.79 | Low | 2.53 | High | 2.75 | Mkt Cap | 14.35M |
| Vol | 664.37K | Avg Vol | 495.83K | EPS | -16.16 | P/E | N/A | Forward P/E | -0.29 |
| Beta | 1.86 | Short Ratio | 0.36 | Inst. Own | 15.34% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-08 | 50-d Avg | 2.58 | 200-d Avg | 5.44 | 1yr Est | 18.00 |
MBRX News
benzinga.com
Why is Moleculin Stock Falling Today?
Moleculin Biotech Inc. (NASDAQ:MBRX) stock is trading lower on Tuesday after the company shared prel
benzinga.com
Why is Moleculin Stock Falling Today?
Moleculin reports interim Phase 2/3 trial data as Annamycin shows higher remission rates than contro
benzinga.com
Moleculin Biotech Announces Its Data From Phase 2/3 MIRACLE Study For Both Annamycin Treatment Arms
Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), today announ
globenewswire.com
Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rate
Both Annamycin dose arms outperformed control on the primary endpoint of complete remission (CR): 43
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Aditxt (NASDAQ:ADTX) shares increased by 151.6% to $0.05 during Tuesday's regular sessi
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers HeartSciences (NASDAQ:HSCS) stock rose 82.2% to $3.23 during Tuesday's pre-market sessi
benzinga.com
Moleculin Biotech Enrolls 45th Participant In Its Pivotal Phase 2B/3 MIRACLE Study Of Annamycin In
Moleculin Biotech, Inc., (NASDAQ:MBRX) ("Moleculin" or the "Company"), today announc